The possession of the CYP2C9*3 allele is associated with low dose requirement of acenocoumarol

被引：47

作者：

Thijssen, HHW

Verkooijen, IWC

Frank, HLL

机构：

[1] Univ Maastricht, Dept Pharmacol, NL-6200 MD Maastricht, Netherlands

[2] Thrombosis Serv Ctr, Maastricht, Netherlands

来源：

PHARMACOGENETICS | 2000年 / 10卷 / 08期

关键词：

genetic polymorphism; CYP2C9; CYP2C19; acenocoumarol;

D O I：

10.1097/00008571-200011000-00010

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

[No abstract available]

引用

页码：757 / 760

页数：4

共 27 条

[1] Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications
Aithal, GP
Day, CP
Kesteven, PJL
Daly, AK
[J]. LANCET, 1999, 353 (9154) : 717 - 719
[2] The R144C change in the CYP2C9*2 allele alters interaction of the cytochrome P450 with NADPH:cytochrome P450 oxidoreductase
Crespi, CL
Miller, VP
[J]. PHARMACOGENETICS, 1997, 7 (03): : 203 - 210
[3] No effect of short-term omeprazole intake on acenocoumarol pharmacokinetics and pharmacodynamics
deHoon, JNJM
Thijssen, HHW
Beysens, AJMM
VanBortel, LMAB
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 44 (04) : 399 - 401
[4] DEMORAIS SMF, 1994, MOL PHARMACOL, V46, P594
[5] DEMORAIS SMF, 1994, J BIOL CHEM, V269, P15419
[6] Ferguson RJ, 1998, J PHARMACOL EXP THER, V284, P356
[7] Genetic polymorphism of CYP2C9 and its effect on warfarin maintenance dose requirement in patients undergoing anticoagulation therapy
Furuya, H
FernandezSalguero, P
Gregory, W
Taber, H
Steward, A
Gonzalez, FJ
Idle, JR
[J]. PHARMACOGENETICS, 1995, 5 (06): : 389 - 392
[8] STEREOSPECIFIC ASSAY OF NICOUMALONE - APPLICATION TO PHARMACOKINETIC STUDIES IN MAN
GILL, TS
HOPKINS, KJ
ROWLAND, M
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 25 (05) : 591 - 598
[9] HUMAN LIVER MICROSOMAL METABOLISM OF THE ENANTIOMERS OF WARFARIN AND ACENOCOUMAROL - P450 ISOZYME DIVERSITY DETERMINES THE DIFFERENCES IN THEIR PHARMACOKINETICS
HERMANS, JJR
THIJSSEN, HHW
[J]. BRITISH JOURNAL OF PHARMACOLOGY, 1993, 110 (01) : 482 - 490
[10] Polymorphism of the cytochrome P450 (CYP) 2C9 gene in Japanese epileptic patients:: genetic analysis of the CYP2C9 locus
Imai, J
Ieiri, I
Mamiya, K
Miyahara, S
Furuumi, H
Nanba, E
Yamane, M
Fukumaki, Y
Ninomiya, H
Tashiro, N
Otsubo, K
Higuchi, S
[J]. PHARMACOGENETICS, 2000, 10 (01): : 85 - 89

← 1 2 3 →